Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Delvit Syrup is a multivitamin supplement manufactured by P&B Pharmaceuticals. It is formulated as an oral liquid preparation intended to prevent or treat vitamin deficiencies and support overall health, particularly in children, elderly patients, and individuals recovering from illness. The syrup typically contains a combination of essential micronutrients, including Vitamin A, Vitamin D3, and various B-complex vitamins such as Thiamine (B1), Riboflavin (B2), Pyridoxine (B6), and Cyanocobalamin (B12), often supplemented with Nicotinamide and D-Panthenol. These components function as vital cofactors in numerous metabolic pathways, including energy production, DNA synthesis, and immune system maintenance. As a finished consumer health product, it is marketed as an over-the-counter (OTC) nutritional aid rather than a novel therapeutic candidate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Delvit Syrup.